Catalog · Industry and sector · D14

Healthcare, Pharma and Biotech (Part 3): Biotech

For biotechnology companies, biologics manufacturers, and the teams that partner with them. Covers biologics and biosimilars, drug discovery platforms, manufacturing and cold chain, cell and gene therapy operations, IP and partnering, and AI in biotech.

21 Capability Courses · 20 Foundation · 1 Intermediate

Request a demo See it in the full catalog

Capability Courses in this group

CodeCapability CourseLevel
IN-HCL3-101Biotech Applications Across Health, Industry, and EnvironmentFoundation
IN-HCL3-102Biologics vs. Small MoleculesFoundation
IN-HCL3-103Biologic Modalities and Their Clinical and Industrial UsesFoundation
IN-HCL3-104Process-Specific Manufacturing and Regulatory Implications for BiologicsFoundation
IN-HCL3-105Global Biotechnology Industry Structure and Regional DynamicsFoundation
IN-HCL3-106Biosimilars: Development, Approval, and Global Market DynamicsFoundation
IN-HCL3-107Cold Chain Logistics and Advanced Therapy DistributionFoundation
IN-HCL3-108Positioning in the Global Biotech Value ChainFoundation
IN-HCL3-109Translational Science: Evidence Appraisal and Program DesignIntermediate
IN-HCL3-110Drug Discovery, Development, and Biotechnology PlatformsFoundation
IN-HCL3-111Biomarkers, Patient Selection, and Regulatory SubmissionFoundation
IN-HCL3-112Intellectual Property, Patent Strategy, and Freedom to OperateFoundation
IN-HCL3-113Partnering, Licensing, and Portfolio Decision-MakingFoundation
IN-HCL3-114Biologics Manufacturing: Contamination Control and In-Process MonitoringFoundation
IN-HCL3-115Upstream and Downstream Processes in Biologics ProductionFoundation
IN-HCL3-116Technology Transfer, Scale-Up, and Change ManagementFoundation
IN-HCL3-117Advanced Therapies: Cell and Gene Therapy OperationsFoundation
IN-HCL3-118Vector Manufacturing and Advanced Therapy Supply ChainsFoundation
IN-HCL3-119Potency Testing, Release, and Hospital Interface for Living ProductsFoundation
IN-HCL3-120Long-Term Follow-Up and Pharmacovigilance in Cell and Gene TherapyFoundation
IN-HCL3-121Artificial Intelligence in Biotechnology: Tools, Integration, and Future PotentialFoundation

More in Industry and sector

Related groups

See Healthcare, Pharma and Biotech (Part 3): Biotech mapped to your organization.

A short walkthrough of these Capability Courses, the platform, and your deployment options.

Request a demo